Reporter February 2024
Feb. 29, 2024—Vanderbilt's Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).
Feb. 29, 2024—Vanderbilt University Medical Center has received a federal grant of nearly $500,000 to expand access to Sexual Assault Nurse Examiners (SANEs) across Middle Tennessee, particularly to rural and underserved areas. The grant, from the U.S. Department of Justice’s Office for Victims of Crime, is awarded to increase the number and availability of SANEs and sexual...
Feb. 29, 2024—The Multicenter Orthopaedic Outcomes Network (MOON) Shoulder Group received the 2024 Kappa Delta Ann Doner Vaughn Award for advancing treatment methods for patients with atraumatic, symptomatic rotator cuff tears.
Feb. 29, 2024—Vanderbilt's Heather Burrell Ward, MD, has received a five-year, $928,000 grant from the National Institute on Drug Abuse to test whether an externally applied magnetic field can reduce nicotine craving in people with schizophrenia.
Study finds more pleasant-sounding medical device alarms could reduce annoyance without compromising effectiveness
Feb. 29, 2024—A new study found that making medical device alarms more musical can significantly reduce perceived annoyance without negatively impacting the ability of research participants to learn and remember the alarms.
Feb. 27, 2024—Multi-institutional study finds that enrollment and outcomes were similar across racial and ethnic groups for children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide.
Feb. 27, 2024—Vanderbilt's Brad Malin, PhD, was recently elected a fellow of the Institute of Electrical and Electronics Engineers for his contributions to data engineering, privacy and security in biomedicine.
Feb. 27, 2024—The latest analysis of the 2024 Tennessee Child Health Poll has found that the proportion of uninsured kids in Tennessee held steady from the 2023 poll, and the rates of mental health diagnoses and associated concerns from Tennessee parents remain high.
Feb. 27, 2024—Emily Kneussle, a 20-year-old aspiring professional ballerina, was “born a dancer.” When a tumor in her brain threatened her dreams, Monroe Carell Jr. Children’s Hospital at Vanderbilt helped her get back on stage.
Feb. 26, 2024—Vanderbilt researchers are using artificial intelligence to search for existing drugs used for other problems that might help patients Alzheimer's Disease.
Monroe Carell Jr. Children’s Hospital at Vanderbilt begins treating patients with novel gene therapy for Duchenne muscular dystrophy
Feb. 23, 2024—Monroe Carell Jr. Children’s Hospital at Vanderbilt's Jonathan Soslow, MD, and Bryan Burnette, MD, recently began treating patients with a novel gene therapy for Duchenne muscular dystrophy.
NIH-funded trial to determine if immunomodulation can improve brain and cardiovascular dysfunction in Long COVID
Feb. 22, 2024—Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.